Literature DB >> 12621591

Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis.

Maria J Bartolome Pacheco1, Jose A Amado, Marcos Lopez-Hoyos, Ricardo Blanco, Maria T Garcia-Unzueta, Vicente Rodriguez-Valverde, Victor M Martinez-Taboada.   

Abstract

BACKGROUND: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are 2 closely related syndromes affecting elderly people. One of the most striking features of these conditions is the development of the disease in an almost exclusive manner in people older than 50 years. Despite this close association with age, the pathogenic mechanisms that could explain this age-related predisposition are unknown. Aging is accompanied by a number of quantitative and qualitative changes in the endocrine system that may predispose to several pathologic conditions that occur in the elderly.
OBJECTIVE: To explore the hypothalamic-pituitary-adrenal axis in PMR and GCA.
METHODS: Basal levels of adrenal hormones as well as the response to low-dose adrenocorticotropin hormone (ACTH) were investigated in 20 patients with active untreated disease and compared with levels in 16 healthy age-matched controls.
RESULTS: Male patients with active disease had low basal levels of androstenedione compared to the controls. After low-dose ACTH challenge, cortisol and dehydroepiandrosterone reached higher levels in patients than in healthy subjects, indicating that the adrenal gland function was not suppressed. Furthermore, the authors did not find a clear relationship between the levels of acute phase reactants and adrenal hormones in the patient population.
CONCLUSIONS: The authors' findings are probably more compatible with the hypothesis that the abnormalities found in the patient group are the consequences of chronic illness rather than a crucial factor contributing to the pathogenesis of the disease. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621591     DOI: 10.1053/sarh.2003.49993

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  5 in total

1.  A case of apoplectic lymphocytic hypophysitis complicated by polymyalgia rheumatica.

Authors:  Yasuko Tanaka; Tomohito Hirao; Keisuke Tsutsumi; Taiichiro Miyashita; Yasumori Izumi; Yumi Mihara; Masahiro Ito; Hiroshi Baba; Kiysohi Migita
Journal:  Rheumatol Int       Date:  2010-06-01       Impact factor: 2.631

2.  Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  M Lopez-Hoyos; M J Bartolome-Pacheco; R Blanco; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

3.  Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment.

Authors:  Frederik Flindt Kreiner; Henrik Galbo
Journal:  Arthritis Res Ther       Date:  2012-08-15       Impact factor: 5.156

4.  A Case of Transient ACTH Deficiency Associated with Polymyalgia Rheumatica.

Authors:  Hitoo Nishi; Yuichi Nishi; Masato Yagita; Yoshiko Tamaru; Sadayuki Matsumoto; Hiroyuki Koshiyama
Journal:  Jpn Clin Med       Date:  2010-12-19

5.  Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort study.

Authors:  Yvan Jamilloux; Eric Liozon; Gregory Pugnet; Sylvie Nadalon; Kim Heang Ly; Stephanie Dumonteil; Guillaume Gondran; Anne-Laure Fauchais; Elisabeth Vidal
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.